27. Idiopathic basal ganglia calcification Clinical trials / Disease details
Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05662111 (ClinicalTrials.gov) | February 2023 | 16/11/2022 | Treatment of Ectopic Calcification in Fahr's Disease or Syndrome | A Randomized, Placebo-controlled, Double Blind Trial to Study the Effects of Etidronate on Ectopic CALCIfication in FAhr's Disease or Syndrome | Fahr Disease;Fahr Syndrome;Primary Familial Brain Calcification | Drug: Etidronate;Drug: Placebo | UMC Utrecht | Netherlands Brain Foundation | Not yet recruiting | 18 Years | N/A | All | 96 | Phase 2 | NULL |